{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:34:38Z","timestamp":1790429678930,"version":"4.1.0"},"reference-count":55,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["16204519"],"award-info":[{"award-number":["16204519"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an imminent need to better understand this new virus and to develop ways to control its spread. In this study, we sought to gain insights for vaccine design against SARS-CoV-2 by considering the high genetic similarity between SARS-CoV-2 and SARS-CoV, which caused the outbreak in 2003, and leveraging existing immunological studies of SARS-CoV. By screening the experimentally-determined SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins. As no mutation has been observed in these identified epitopes among the 120 available SARS-CoV-2 sequences (as of 21 February 2020), immune targeting of these epitopes may potentially offer protection against this novel virus. For the T cell epitopes, we performed a population coverage analysis of the associated MHC alleles and proposed a set of epitopes that is estimated to provide broad coverage globally, as well as in China. Our findings provide a screened set of epitopes that can help guide experimental efforts towards the development of vaccines against SARS-CoV-2.<\/jats:p>","DOI":"10.3390\/v12030254","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T04:18:29Z","timestamp":1582690709000},"page":"254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":794,"title":["Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-0307","authenticated-orcid":false,"given":"Syed Faraz","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-9067","authenticated-orcid":false,"given":"Ahmed A.","family":"Quadeer","sequence":"additional","affiliation":[{"name":"Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"McKay","sequence":"additional","affiliation":[{"name":"Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong, China"},{"name":"Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2020, January 31). Centers-of-Disease-Control-and-Prevention Confirmed 2019-nCoV cases globally, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/locations-confirmed-cases.html."},{"key":"ref_3","unstructured":"(2020, January 31). World-Health-Organization Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available online: https:\/\/www.who.int\/news-room\/detail\/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)."},{"key":"ref_4","unstructured":"(2020, January 31). World-Health-Organization Coronavirus disease (COVID-19) outbreak. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"ref_5","unstructured":"(2020, January 31). World-Health-Organization Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available online: https:\/\/www.who.int\/news-room\/detail\/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(20)30184-7","article-title":"Data sharing and outbreaks: Best practice exemplified","volume":"395","author":"Heymann","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liu, X., and Wang, X.-J. (2020). Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines. bioRxiv, 2020.01.29.924100.","DOI":"10.1101\/2020.01.29.924100"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., and Huang, C.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature.","DOI":"10.1038\/s41586-020-2951-z"},{"key":"ref_10","unstructured":"(2020, January 31). World-Health-Organization Update 49 - SARS case fatality ratio, incubation period. Available online: https:\/\/www.who.int\/csr\/sars\/archive\/2003_05_07a\/en\/."},{"key":"ref_11","unstructured":"(2020, January 31). World-Health-Organization Middle East respiratory syndrome coronavirus (MERS-CoV). Available online: https:\/\/www.who.int\/emergencies\/mers-cov\/en\/."},{"key":"ref_12","first-page":"1","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"6736","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Letko, M., and Munster, V. (2020). Functional assessment of cell entry and receptor usage for lineage B \u03b2-coronaviruses, including 2019-nCoV. bioRxiv, 2020.01.22.915660.","DOI":"10.1101\/2020.01.22.915660"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Kleine-Weber, H., Kruger, N., Muller, M., Drosten, C., and Pohlmann, S. (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv, 2020.01.31.929042.","DOI":"10.1101\/2020.01.31.929042"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., and Pickles, R. (2006). Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030525"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/nm.2972","article-title":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease","volume":"18","author":"Graham","year":"2012","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cr.7290158","article-title":"Identification of an epitope of SARS-coronavirus nucleocapsid protein","volume":"13","author":"Lin","year":"2003","journal-title":"Cell Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1373\/clinchem.2003.023184","article-title":"Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus","volume":"49","author":"Wang","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/CDLI.11.1.227-228.2004","article-title":"Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients","volume":"11","author":"Liu","year":"2004","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: A six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.virol.2006.03.036","article-title":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients","volume":"351","author":"Peng","year":"2006","journal-title":"Virology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: An open bioinformatics database and analysis resource for virology research","volume":"40","author":"Pickett","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/cmb.2014.0156","article-title":"PASTA: Ultra-large multiple sequence alignment for nucleotide and amino-acid sequences","volume":"22","author":"Mirarab","year":"2015","journal-title":"J. Comput. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sysbio\/sys062","article-title":"Dendroscope 3: An interactive tool for rooted phylogenetic trees and networks","volume":"61","author":"Huson","year":"2012","journal-title":"Syst. Biol."},{"key":"ref_33","unstructured":"Ahmed, S.F. (2020, January 31). Data and software code for reproducing results of this paper. Available online: https:\/\/github.com\/faraz107\/2019-nCoV-T-Cell-Vaccine-Candidates."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.1073\/pnas.1105315108","article-title":"Coordinate linkage of HIV evolution reveals regions of immunological vulnerability","volume":"108","author":"Dahirel","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1128\/JVI.03812-13","article-title":"Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design","volume":"88","author":"Quadeer","year":"2014","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1093\/bioinformatics\/btz524","article-title":"Sub-dominant principal components inform new vaccine targets for HIV Gag","volume":"35","author":"Ahmed","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Quadeer, A.A., Morales-Jimenez, D., and McKay, M.R. (2018). Co-evolution networks of HIV\/HCV are modular with direct association to structure and function. PLOS Comput. Biol., 14.","DOI":"10.1101\/307033"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15829","DOI":"10.1074\/jbc.M600697200","article-title":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody","volume":"281","author":"Prabakaran","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34610","DOI":"10.1074\/jbc.M603275200","article-title":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R","volume":"281","author":"Hwang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_42","unstructured":"(2020, January 31). UniProt UniProtKB - P59594 (SPIKE_CVHSA). Available online: https:\/\/www.uniprot.org\/uniprot\/P59594."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Walls, A.C., Park, Y.-J., Tortorici, M.A., Wall, A., McGuire, A.T., and Veesler, D. (2020). Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. bioRxiv, 2020.02.19.956581.","DOI":"10.1101\/2020.02.19.956581"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","article-title":"Unexpected receptor functional mimicry elucidates activation of coronavirus fusion","volume":"176","author":"Walls","year":"2019","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Song, W., Gui, M., Wang, X., and Xiang, Y. (2018). Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLOS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007236"},{"key":"ref_47","first-page":"eabb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"2011","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2012.11.022","article-title":"Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design","volume":"38","author":"Ferguson","year":"2013","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"032601","DOI":"10.1088\/1361-6633\/aa574a","article-title":"Rational design of vaccine targets and strategies for HIV: A crossroad of statistical physics, biology, and medicine","volume":"80","author":"Chakraborty","year":"2017","journal-title":"Reports Prog. Phys."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-019-09819-1","article-title":"Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them","volume":"10","author":"Quadeer","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E564","DOI":"10.1073\/pnas.1717765115","article-title":"Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies","volume":"115","author":"Louie","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41467-019-14174-2","article-title":"Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape","volume":"11","author":"Quadeer","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Mann, J.K., Barton, J.P., Ferguson, A.L., Omarjee, S., Walker, B.D., Chakraborty, A., and Ndung\u2019u, T. (2014). The fitness landscape of HIV-1 Gag: Advanced modeling approaches and validation of model predictions by in vitro testing. PLoS Comput. Biol., 10.","DOI":"10.1371\/journal.pcbi.1003776"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ramaiah, A., and Arumugaswami, V. (2020). Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development. bioRxiv, 2020.01.29.925867.","DOI":"10.1101\/2020.01.29.925867"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/3\/254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:01:38Z","timestamp":1760173298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/3\/254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["v12030254"],"URL":"https:\/\/doi.org\/10.3390\/v12030254","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.02.03.933226","asserted-by":"object"}]},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]}}}